Back to search
Osteogenesis Imperfecta (OI)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Osteogenesis Imperfecta (OI) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Osteogenesis Imperfecta (OI) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is to evaluate the safety and efficacy of AGA2115 at three different dose regimens in Chinese adults and adolescents with Type I, III, or IV Osteogen…
This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.
Osteogenesis Imperfecta-related hearing loss usually occurs in individuals with mild (type I) OI and is much earlier in onset than age-related hearing loss, wit…
This prospective observational investigation will examine the incidence and progression of cardiologic findings in individuals with OI across different age grou…
The study is designed as a retrospective, multicenter study for subjects previously treated with the AGN1 LOEP Kit in the proximal femur as part of standard hos…
This is a Phase 1/2 study to determine the safety and efficacy of allogeneic (third party), bone-marrow derived mesenchymal stromal cells (MSCs) for the treatme…